Solid State Characterization of Ciprofloxacin Liposome Nanocrystals

Tang Li, Stephen Mudie, David Cipolla, Thomas Rades, Ben J. Boyd

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Liposomes have been widely researched as drug delivery systems; however, the solid state form of drug inside the liposome, whether it is in solution or in a solid state, is often not studied. The solid state properties of the drug inside the liposomes are important, as they dictate the drug release behavior when the liposomes come into contact with physiological fluid. Recently, a new approach of making liposomal ciprofloxacin nanocrystals was proposed by the use of an additional freeze-thawing step in the liposomal preparation method. This paper aims to determine the solid state properties of ciprofloxacin inside the liposomes after this additional freeze-thawing cycle using cryo-TEM, small-angle X-ray scattering (SAXS), and cross-polarized light microscopy (CPLM). Ciprofloxacin precipitated in the ciprofloxacin hydrate crystal form with a unit cell dimension of 16.7 Å. The nanocrystals also showed a phase transition at 93 °C, which represents dehydration of the hydrate crystals to the anhydrate form of ciprofloxacin, verified by temperature-dependent SAXS measurements. Furthermore, the dependence of the solid state form of the nanocrystals on pH was investigated in situ, and it was shown that the liposomal ciprofloxacin nanocrystals retained their crystalline form at pH 6-10. Understanding the solid state attributes of nanocrystals inside liposomes provides improved understanding of drug dissolution and release as well as opening avenues to new applications where the nanosized crystals can provide a dissolution benefit.

Original languageEnglish
Pages (from-to)184-194
Number of pages11
JournalMolecular Pharmaceutics
Volume16
Issue number1
DOIs
Publication statusPublished - 7 Jan 2019

Keywords

  • ciprofloxacin
  • cryo-TEM
  • liposomes
  • nanocrystals
  • small-angle X-ray scattering
  • solid state

Cite this

Li, Tang ; Mudie, Stephen ; Cipolla, David ; Rades, Thomas ; Boyd, Ben J. / Solid State Characterization of Ciprofloxacin Liposome Nanocrystals. In: Molecular Pharmaceutics. 2019 ; Vol. 16, No. 1. pp. 184-194.
@article{fad06b36e94046c294f5cb1b7f049c76,
title = "Solid State Characterization of Ciprofloxacin Liposome Nanocrystals",
abstract = "Liposomes have been widely researched as drug delivery systems; however, the solid state form of drug inside the liposome, whether it is in solution or in a solid state, is often not studied. The solid state properties of the drug inside the liposomes are important, as they dictate the drug release behavior when the liposomes come into contact with physiological fluid. Recently, a new approach of making liposomal ciprofloxacin nanocrystals was proposed by the use of an additional freeze-thawing step in the liposomal preparation method. This paper aims to determine the solid state properties of ciprofloxacin inside the liposomes after this additional freeze-thawing cycle using cryo-TEM, small-angle X-ray scattering (SAXS), and cross-polarized light microscopy (CPLM). Ciprofloxacin precipitated in the ciprofloxacin hydrate crystal form with a unit cell dimension of 16.7 {\AA}. The nanocrystals also showed a phase transition at 93 °C, which represents dehydration of the hydrate crystals to the anhydrate form of ciprofloxacin, verified by temperature-dependent SAXS measurements. Furthermore, the dependence of the solid state form of the nanocrystals on pH was investigated in situ, and it was shown that the liposomal ciprofloxacin nanocrystals retained their crystalline form at pH 6-10. Understanding the solid state attributes of nanocrystals inside liposomes provides improved understanding of drug dissolution and release as well as opening avenues to new applications where the nanosized crystals can provide a dissolution benefit.",
keywords = "ciprofloxacin, cryo-TEM, liposomes, nanocrystals, small-angle X-ray scattering, solid state",
author = "Tang Li and Stephen Mudie and David Cipolla and Thomas Rades and Boyd, {Ben J.}",
year = "2019",
month = "1",
day = "7",
doi = "10.1021/acs.molpharmaceut.8b00940",
language = "English",
volume = "16",
pages = "184--194",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "1",

}

Solid State Characterization of Ciprofloxacin Liposome Nanocrystals. / Li, Tang; Mudie, Stephen; Cipolla, David; Rades, Thomas; Boyd, Ben J.

In: Molecular Pharmaceutics, Vol. 16, No. 1, 07.01.2019, p. 184-194.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Solid State Characterization of Ciprofloxacin Liposome Nanocrystals

AU - Li, Tang

AU - Mudie, Stephen

AU - Cipolla, David

AU - Rades, Thomas

AU - Boyd, Ben J.

PY - 2019/1/7

Y1 - 2019/1/7

N2 - Liposomes have been widely researched as drug delivery systems; however, the solid state form of drug inside the liposome, whether it is in solution or in a solid state, is often not studied. The solid state properties of the drug inside the liposomes are important, as they dictate the drug release behavior when the liposomes come into contact with physiological fluid. Recently, a new approach of making liposomal ciprofloxacin nanocrystals was proposed by the use of an additional freeze-thawing step in the liposomal preparation method. This paper aims to determine the solid state properties of ciprofloxacin inside the liposomes after this additional freeze-thawing cycle using cryo-TEM, small-angle X-ray scattering (SAXS), and cross-polarized light microscopy (CPLM). Ciprofloxacin precipitated in the ciprofloxacin hydrate crystal form with a unit cell dimension of 16.7 Å. The nanocrystals also showed a phase transition at 93 °C, which represents dehydration of the hydrate crystals to the anhydrate form of ciprofloxacin, verified by temperature-dependent SAXS measurements. Furthermore, the dependence of the solid state form of the nanocrystals on pH was investigated in situ, and it was shown that the liposomal ciprofloxacin nanocrystals retained their crystalline form at pH 6-10. Understanding the solid state attributes of nanocrystals inside liposomes provides improved understanding of drug dissolution and release as well as opening avenues to new applications where the nanosized crystals can provide a dissolution benefit.

AB - Liposomes have been widely researched as drug delivery systems; however, the solid state form of drug inside the liposome, whether it is in solution or in a solid state, is often not studied. The solid state properties of the drug inside the liposomes are important, as they dictate the drug release behavior when the liposomes come into contact with physiological fluid. Recently, a new approach of making liposomal ciprofloxacin nanocrystals was proposed by the use of an additional freeze-thawing step in the liposomal preparation method. This paper aims to determine the solid state properties of ciprofloxacin inside the liposomes after this additional freeze-thawing cycle using cryo-TEM, small-angle X-ray scattering (SAXS), and cross-polarized light microscopy (CPLM). Ciprofloxacin precipitated in the ciprofloxacin hydrate crystal form with a unit cell dimension of 16.7 Å. The nanocrystals also showed a phase transition at 93 °C, which represents dehydration of the hydrate crystals to the anhydrate form of ciprofloxacin, verified by temperature-dependent SAXS measurements. Furthermore, the dependence of the solid state form of the nanocrystals on pH was investigated in situ, and it was shown that the liposomal ciprofloxacin nanocrystals retained their crystalline form at pH 6-10. Understanding the solid state attributes of nanocrystals inside liposomes provides improved understanding of drug dissolution and release as well as opening avenues to new applications where the nanosized crystals can provide a dissolution benefit.

KW - ciprofloxacin

KW - cryo-TEM

KW - liposomes

KW - nanocrystals

KW - small-angle X-ray scattering

KW - solid state

UR - http://www.scopus.com/inward/record.url?scp=85058163691&partnerID=8YFLogxK

U2 - 10.1021/acs.molpharmaceut.8b00940

DO - 10.1021/acs.molpharmaceut.8b00940

M3 - Article

VL - 16

SP - 184

EP - 194

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 1

ER -